Atlas Molecular Pharma to Begin Dosing First Patients in Phase 2 Trial of ATL-001 for Cong... 03/09/2026 Healthcare Rare diseases Innovative drugs Atlas Molecular Pharma, a Basque biotech developing pharmacological chaperone therapies for rare diseases, announces... Partners - Atlas Molecular Pharma
Spanish Society for Haematology and Haemotherapy, SpotLab, and GSK are launching MedulAI, ... 02/09/2026 Healthcare Access to innovation In vitro diagnostics This pioneering project in Spain aims to support the diagnosis of haematological diseases through AI applied to bone... Partners - GSK
Batea Oncology and dsm-firmenich Partner to Support Clinical Development of GlioHook® for ... 02/09/2026 Healthcare Innovative drugs Advanced therapies Batea Oncology and dsm-firmenich are building on a longstanding collaboration dedicated to advancing GlioHook®, an... Partners - BATEA ONCOLOGY S.L.
Biometriks Health, Ubikare, vitalera, Athlon y Cuico Health selected to present at the Hea... 01/09/2026 Healthcare Access to innovation Personalized medicine Partners - UBIKARE
Driving medicine that transforms clinical data into evidence with AI 01/09/2026 Healthcare Access to innovation Digitalization The Autonomous University of Madrid (UAM) will host the first edition of BSD Data Days on 15 October, an event promoted... Partners - BIOGA
ORYZON announces Notice of Allowance for U.S. patent application covering iadademstat com... 31/08/2026 Healthcare Drug discovery Innovative drugs Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination with gilteritinib in... Partners - Oryzon Genomics
Neural Omega to present its full molecular mimicry pipeline at BioSpain 2026 31/08/2026 Healthcare Access to innovation Drug discovery From clinical data to drug discovery: Madrid-based biotech Neural Omega will make its international debut at BioSpain... Partners - NEURAL OMEGA
Almirall and Certest Biotec enter strategic research collaboration and licensing agreement 31/08/2026 Healthcare Rare diseases Innovative drugs Almirall and Certest Biotec, S.L., through its pharmaceutical division, Certest Pharma, have entered into a strategic... Partners - CERTEST BIOTEC
Regulatory Shifts Ahead: Preparing for FDA Changes and EU Pharmaceutical Reform Online Del 16/09/2026 to 16/09/2026 Healthcare Access to innovation Innovative drugs
Accelerating Pre-Clinical Large-Molecule Screening with an Integrated DMPK/ADME Approach Online Del 02/09/2026 to 02/09/2026 Healthcare Innovative drugs Advanced therapies
